Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Completed 3

Sponsor Class

NETWORK 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1CNS 1

Conditions

Leukemia 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Genetic Linkage × Clear all
NCT01557959 2018-06-29

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Wake Forest University Health Sciences

Phase 2 Completed
45 enrolled 9 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT01119586 2016-07-11

Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

Children's Oncology Group

Completed
350 enrolled
Other hematologic neoplasm

Leukemia

NCT01585389 2016-05-18

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Children's Oncology Group

Completed
10 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡